Allergan launches antioxidant cream
US health care company Allergan has launched its Prevage (idebenone) cream which, according to the group, represents the only available clinically-tested antioxidant that reduces the appearance of fine lines and wrinkles as well as providing protection against environmental factors.
Results from a six-week clinical study evaluating Prevage (1% idebenone) in 21 women aged 18-65 with moderate photoaging showed: a 29% reduction in the appearance of fine lines and wrinkles; 26% less skin roughness or dryness; a 37% increase in skin hydration; and 33% overall global improvement in the appearance of skin, Allergan said.
"The unique formulation of Prevage allows it to penetrate the skin at the cellular level to help prevent free radicals from breaking down the collagen and elastin in the skin," added Jeanine Downie, director of US clinic Image Dermatology.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze